C-terminal truncation of the hemagglutinin-neuraminidase (HN) protein enhances the virulence and immunogenicity of Newcastle disease virus (NDV) vaccine strain V4

文献类型: 外文期刊

第一作者: Ren, Xiangfei

作者: Ren, Xiangfei;Zeng, Zhe;Shang, Yu;Yao, Lun;Li, Li;Zhang, Wenting;Guo, Yunqing;Wang, Hongcai;Zhang, Rongrong;Shao, Huabin;Luo, Qingping;Wen, Guoyuan;Ren, Xiangfei;Zeng, Zhe;Shang, Yu;Yao, Lun;Li, Li;Zhang, Wenting;Guo, Yunqing;Wang, Hongcai;Zhang, Rongrong;Shao, Huabin;Luo, Qingping;Wen, Guoyuan;Ren, Xiangfei;Hu, Sishun;Luo, Qingping

作者机构:

关键词: Newcastle disease virus; HN protein; C-terminal; Virulence; Immunogenicity

期刊名称:ARCHIVES OF VIROLOGY ( 影响因子:2.7; 五年影响因子:2.4 )

ISSN: 0304-8608

年卷期: 2023 年 168 卷 8 期

页码:

收录情况: SCI

摘要: The hemagglutinin-neuraminidase (HN) protein of Newcastle disease virus (NDV) is a multifunctional protein with receptor recognition ability that plays an important role in the infection of cells by NDV. An alignment of NDV HN protein sequences of different genotypes showed that vaccine strains of NDV, such as the LaSota strain, generally have an HN protein of 577 amino acids. In comparison, the HN protein of the V4 strain has 616 amino acids, with 39 more amino acids at the C-terminus. In this study, we generated a recombinant NDV (rNDV) with a 39-amino-acid truncation at the HN C-terminus based on the full-length cDNA clone of the V4 strain. This rNDV, named rV4-HN-tr, displayed thermostability similar to that of the parental V4 strain. However, growth kinetics and pathogenicity analysis suggested that rV4-HN-tr is more virulent than the V4 strain. Notably, the C-terminus of HN affected the ability of the virus to adsorb onto cells. Structural predictions further suggested that the C-terminus of HN may obstruct the sialic acid binding site. Immunization of chickens with rV4-HN-tr induced a 3.5-fold higher level of NDV-specific antibodies than that obtained with the V4 strain and provided 100% immune protection against NDV challenge. Our study suggests that rV4-HN-tr is a thermostable, safe, and highly efficient vaccine candidate against Newcastle disease.

分类号:

  • 相关文献
作者其他论文 更多>>